A consortium led by the University of Minnesota is preparing to seek FDA approval of a potential breakthrough treatment for type 1 diabetes that involves transplanting insulin-producing islet cells. Clinical studies have demonstrated that 60% to 70% of patients receiving the transplants remained insulin-free after five years. Approximately 1.5 million Americans have type 1 diabetes, in which the body destroys its own islet cells.
Researchers seek FDA approval for diabetes cell transplants
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore